This fact sheet is for men who have been diagnosed with localised prostate cancer - cancer that's contained inside the prostate gland. It explains what localised prostate cancer is, what your test results mean, and the treatment options available.


  • Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA; 2005.
  • Berney DM. The case for modifying the Gleason grading system. BJU Int. 2007;100(4):725–6.
  • Burford DC, Kirby M, Austoker J. Prostate Cancer Risk Management Programme: PSA testing in asymptomatic men. Evidence document. NHS Cancer Screen Programme. 2010
  • D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–74.
  • Epstein JI, Allsbrook Jr WC, Amin MB, Egevad LL, Committee IG, others. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29(9):1228–42.
  • European Association of Urology. Guidelines on Prostate Cancer. 2014.
  • Hegarty J, Walsh E, Harry Comber, Tony Fitzgerald, Kazer MW. Radical prostatectomy versus watchful waiting for prostate cancer. Cochrane Database Syst Rev. 2010
  • Husson O, Mols F, Poll-Franse LV van de. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol. 2010 Sep 24;mdq413.
  • MDT Prostate Cancer Guidance (BUG, BAUS). 2013.
  • Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;8:CD007566.
  • National Institute for Health and Clinical Excellence (Great Britain). Low dose rate brachytherapy for localised prostate cancer. London: National Institute for Health and Clinical Excellence; 2005.
  • National Institute for Health and Clinical Excellence. High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer. 2006
  • NICE. Prostate Cancer: diagnosis and treatment. NICE full guideline. 2014.
  • O’Donnell H, Parker C. What is low-risk prostate cancer and what is its natural history? World J Urol. 2008 Oct 1;26(5):415–22.
  • Price CP, Allard J, Davies G, Dawnay A, Duffy MJ, France M, et al. Pre-and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer. Ann Clin Biochem. 2001;38(3):188–216.

About this publication  

Updated: August 2014 | Due for Review: July 2016

Order printed copies of this publication

Before you order we would like to know who you are, and why you are ordering printed copies.

Download digital versions of this publication